General MedicationsINJECTIONStandard
VEGZELMA
BEVACIZUMAB-ADCD
Standard Dose
400MG/16ML(25MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview VEGZELMA is listed in Drugs@FDA under application 761268 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient BEVACIZUMAB-ADCD Form and strength INJECTABLE;INJECTION - 400MG/16ML(25MG/ML) Sponsor CELLTRION Submission history Latest submission status date: 2022-09-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview VEGZELMA is listed in Drugs@FDA under application 761268 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient BEVACIZUMAB-ADCD Form and strength INJECTABLE;INJECTION - 400MG/16ML(25MG/ML) Sponsor CELLTRION Submission history Latest submission status date: 2022-09-27 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.